Search Results for "Alan Bryce" | Oncology Voice Network

Michael Pietrack

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Feb 19^th • 6 mins read

Michael Pietrack

Leadership Lab: How To Spot When Employees Are About To Walk Away

Oct 22^nd • 7 mins read

Michael Pietrack

How to Know When to Make a Job Change

Aug 26^th • 5 mins read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

May 6^th • 18 mins read

Yuan Zhang, Xu Liu, Ying-Qin Li, Ling-Long Tang, Lei Chen, Jun Ma

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure

Aug 12^th • 10 mins read

Shani Paluch-Shimon, Nathan I. Cherny, Elisabeth G.E. de Vries, Urania Dafni, Martine J. Piccart, Nicola Jane Latino, Fatima Cardoso

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Sep 6^th • 20 mins read

Qiyou Wu, Zhiwei Lian, Xin Wang, Hanchao Cheng, Jing Sun, Hui Yu, Gong Zhang, Fan Wu, Jian Liu and Chuanben Chen

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China

Jan 12^th • 13 mins read

P.S. Mishra-Kalyani, L. Amiri Kordestani, D.R. Rivera, H. Singh, A. Ibrahim, R.A. DeClaro, Y. Shen, S. Tang, R. Sridhara, P.G. Kluetz, J. Concato, R. Pazdur, J.A. Beaver

External control arms in oncology: current use and future directions

Jan 9^th • 9 mins read

MAXIMILIAN SALCHER-KONRAD, HUSEYIN NACI, COURTNEY DAVIS

Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States

Oct 6^th • 48 mins read

Jonathon Webster, MD and B. Douglas Smith, MD

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia

Jan 29^th • 10 mins read

Nicole M. Kuderer and Gary H. Lyman

Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety

Jun 20^th • 3 mins read

Envision Pharma Group

AI-powered real-world evidence: Strategically enhancing value and access

Aug 22^nd • 5 mins read

Navigation

Results for 'Alan Bryce'

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Leadership Lab: How To Spot When Employees Are About To Walk Away

How to Know When to Make a Job Change

MSL Evolution: New Trends and Titles That May Emerge

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China

External control arms in oncology: current use and future directions

Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia

Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety

AI-powered real-world evidence: Strategically enhancing value and access

Related Topics